ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Alchemab
Reporting to the ML Director, the Principal Deep Learning Researcher develops and applies deep learning models to Alchemab's antibody discovery pipeline, bridging research and production impact. The role involves designing architectures for sequence understanding and binding prediction, collaborating with cross-functional teams to enable actionable model outputs, and helping define the company's overall ML strategy.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2019
Alchemab Therapeutics is a biotechnology company harnessing the power of the adaptive immune system to develop next-generation antibody therapeutics for hard-to-treat diseases. Their unique approach identifies resilient individuals — such as long-term cancer survivors — and uses leading-edge science and deep learning to create therapeutics from antibodies shared across those resilient populations. The company is advancing its pipeline into clinical trials, including a Phase 1 trial of ATLX-1282, and actively seeks biopharma partnerships.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alchemab.
Alchemab didn’t post a salary, so this is our estimate from similar listings.
23% above the average for this role